Skip to main content

Table 1 Mean (±SD) PFU/well of monkeypox virus treated with silver nanoparticles or silver nitrate

From: A Preliminary Assessment of Silver Nanoparticle Inhibition of Monkeypox Virus Plaque Formation

Treatment Concentration (μg/mL)
100 50 25 12.5 0
Ag-PS-10 10 ± 3.2* 16 ± 7.5* 16 ± 4.7* 19 ± 6.7* a
Ag-PS-25c 58 ± 7.4 50 ± 3.8 47 ± 5.7 42 ± 5.4
Ag-NP-25 74 ± 11 86 ± 7.8 87 ± 7.9 71 ± 3.1
Ag-NP-55c 72 ± 5.7 67 ± 3.1 51 ± 7.4 41 ± 3.8
Ag-PS-80 71 ± 13 75 ± 6.7 67 ± 7.0 61 ± 7.0
Ag-NP-80 50 ± 16 47 ± 15 40 ± 16 36 ± 15
AgNO3 NDb 34 ± 10* 33 ± 5.2* 29 ± 8.8*
Control 48 ± 9.9
Blank 0 0 0 0 0
  1. aNot applicable
  2. bNot determined due to observed cytotoxicity
  3. cSignificant effect of all test compound concentrations on mean PFU/well (one-way ANOVA;P ≤ 0.05)
  4. * Mean value is significantly lower than control (t-test;P ≤ 0.05)